These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
748 related articles for article (PubMed ID: 32527770)
1. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer. Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770 [TBL] [Abstract][Full Text] [Related]
2. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study. Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254 [TBL] [Abstract][Full Text] [Related]
4. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy. Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626 [TBL] [Abstract][Full Text] [Related]
5. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes. Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and toxicity of postoperative intensity-modulated versus three-dimensional conformal radiation therapy in patients with cervical cancer. Lan ML; Yu X; Xiao H; Zhou P; Hu N; Li J; Wang G Asia Pac J Clin Oncol; 2016 Dec; 12(4):430-436. PubMed ID: 26923341 [TBL] [Abstract][Full Text] [Related]
7. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases. Chung YL; Horng CF; Lee PI; Chen FL BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959 [TBL] [Abstract][Full Text] [Related]
8. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy]. Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience. Lee J; Lin JB; Sun FJ; Chen YJ; Chang CL; Jan YT; Wu MH Medicine (Baltimore); 2017 Mar; 96(10):e6158. PubMed ID: 28272204 [TBL] [Abstract][Full Text] [Related]
12. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group. Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333 [TBL] [Abstract][Full Text] [Related]
13. Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy. Chen SW; Liang JA; Yang SN; Lin FJ Eur J Gynaecol Oncol; 2004; 25(1):81-6. PubMed ID: 15053068 [TBL] [Abstract][Full Text] [Related]
14. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy. Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330 [TBL] [Abstract][Full Text] [Related]
15. Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients. Tsuchida K; Murakami N; Kato T; Okuma K; Okamoto H; Kashihara T; Takahashi K; Inaba K; Igaki H; Nakayama Y; Nakano T; Itami J J Radiat Res; 2019 Oct; 60(5):650-657. PubMed ID: 31251358 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study. Brodeur MN; Samouëlian V; Dabi Y; Cormier B; Beauchemin MC; Barkati M Int J Gynecol Cancer; 2021 Jan; 31(1):78-84. PubMed ID: 33127863 [TBL] [Abstract][Full Text] [Related]
17. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer]. Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966 [No Abstract] [Full Text] [Related]
18. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era. Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889 [TBL] [Abstract][Full Text] [Related]
19. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy. Chen CC; Wang L; Lin JC; Jan JS J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974 [TBL] [Abstract][Full Text] [Related]